DC-virus interplay: A double edged sword

Seminars in Immunology

Volumn 16, Issue 3, 2004, Pages 147-161

  Larsson, Marie ^a   Beignon, Anne Sophie ^a   Bhardwaj, Nina ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CMV; cytomegalovirus; EBV; Epstein Barr virus; herpes simplex virus 1; herpes simplex virus 2; HHV 6; HPV; HSV 1; HSV 2; human papilloma virus; Langerhans cell; LC; MDC; myeloid dendritic cell; pDC; plasmacytoid dendritic cell; Varicella zoster virus; VZV

Indexed keywords

BETA DEFENSIN; CD11 ANTIGEN; CD123 ANTIGEN; CD34 ANTIGEN; GLYCOPROTEIN GP 96; HEAT SHOCK PROTEIN 60; HEAT SHOCK PROTEIN 70; INTERFERON; INTERLEUKIN 2; INTERLEUKIN 3 RECEPTOR; INTERLEUKIN 6; LECTIN RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN PRESENTATION; APOPTOSIS; B LYMPHOCYTE; BONE MARROW CELL; CELL ACTIVATION; CELL FUNCTION; CELL MATURATION; CELL MIGRATION; CELL POPULATION; CELLULAR DISTRIBUTION; CELLULAR IMMUNITY; CROSS REACTION; CYTOMEGALOVIRUS; DENDRITIC CELL; DERMIS; EFFECTOR CELL; EPIDERMIS; HELPER CELL; HEMATOPOIETIC STEM CELL; HERPES SIMPLEX VIRUS 1; HERPES VIRUS; HLA SYSTEM; HOST CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; INFLUENZA VIRUS; LANGERHANS CELL; LYMPHOID ORGAN; MAJOR HISTOCOMPATIBILITY COMPLEX; MEASLES VIRUS; NATURAL KILLER CELL; NONHUMAN; POXVIRUS; PROTEIN EXPRESSION; REVIEW; T LYMPHOCYTE; TH1 CELL; TH2 CELL; UPREGULATION; VACCINIA VIRUS; VIRUS CELL INTERACTION; VIRUS DETECTION; VIRUS IMMUNITY; VIRUS INFECTION; VIRUS REPLICATION;

DENDRITIC CELLS; HUMANS; VIRUS DISEASES; VIRUSES;

EID: 2342481202     PISSN: 10445323     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.smim.2004.02.002     Document Type: Review

References (198)

1. Liu Y.J., Kanzler H., Soumelis V., Gilliet M. Dendritic cell lineage, plasticity and cross-regulation. Nat. Immunol. 2(7):2001;585-589
2. Steinman R.M. Dendritic cells and the control of immunity: enhancing the efficiency of antigen presentation. Mt. Sinai J. Med. 68:2000;160-166
3. Briere F., Bendriss-Vermare N., Delale T., et al. Origin and filiation of human plasmacytoid dendritic cells. Hum. Immunol. 63(12):2002;1081-1093
4. Fong L., Mengozzi M., Abbey N.W., Herndier B.G., Engleman E.G. Productive infection of plasmacytoid dendritic cells with human immunodeficiency virus type 1 is triggered by CD40 ligation. J. Virol. 76(21):2002;11033-11041
5. Bendriss-Vermare N., Barthelemy C., Durand I., et al. Human thymus contains IFN-alpha-producing CD11c(-) myeloid CD11c(+), and mature interdigitating dendritic cells. J. Clin. Investig. 107(7):2001;835-844
6. Vandenabeele S., Hochrein H., Mavaddat N., Winkel K., Shortman K. Human thymus contains 2 distinct dendritic cell populations. Blood. 97(6):2001;1733-1741
7. Farkas L., Beiske K., Lund-Johansen F., Brandtzaeg P., Jahnsen F.L. Plasmacytoid dendritic cells (natural interferon-alpha/beta-producing cells) accumulate in cutaneous lupus erythematosus lesions. Am. J. Pathol. 159(1):2001;237-243
8. Jahnsen F.L., Lund-Johansen F., Dunne J.F., Farkas L., Haye R., Brandtzaeg P. Experimentally induced recruitment of plasmacytoid (CD123high) dendritic cells in human nasal allergy. J. Immunol. 165(7):2000;4062-4068
9. Banchereau J., Pulendran B., Steinman R., Palucka K. Will the making of plasmacytoid dendritic cells in vitro help unravel their mysteries? J. Exp. Med. 192(12):2000;F39-F44
10. Fonteneau J.F., Gilliet M., Larsson M., et al. Activation of influenza virus-specific CD4+ and CD8+ T cells: a new role for plasmacytoid dendritic cells in adaptive immunity. Blood. 101(9):2003;3520-3526
11. Jego G., Palucka A.K., Blanck J.P., Chalouni C., Pascual V., Banchereau J. Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6. Immunity. 19(2):2003;225-234
12. Turville S.G., Cameron P.U., Handley A., et al. Diversity of receptors binding HIV on dendritic cell subsets [comment]. Nat. Immunol. 3(10):2002;975-983
13. Schneider-Schaulies S., Klagge I.M., ter Meulen V., et al. Dendritic cells and measles virus infection. Curr. Top. Microbiol. Immunol. 276:2003;77-101
14. Matthews K., Leong C.M., Baxter L., et al. Depletion of Langerhans cells in human papillomavirus type 16-infected skin is associated with E6-mediated down regulation of E-cadherin. J. Virol. 77(15):2003;8378-8385
15. Tindle R.W. Immune evasion in human papillomavirus-associated cervical cancer. Nat. Rev. Cancer. 2(1):2002;59-65
16. Zou W., Borvak J., Wei S., Isaeva T., Curiel D.T., Curiel T.J. Reciprocal regulation of plasmacytoid dendritic cells and monocytes during viral infection. Eur. J. Immunol. 31(12):2001;3833-3839
17. Rea D., Schagen F.H., Hoeben R.C., et al. Adenoviruses activate human dendritic cells without polarization toward a T-helper type 1-inducing subset. J. Virol. 73(12):1999;10245-10253
18. Mikloska Z., Bosnjak L., Cunningham A.L. Immature monocyte-derived dendritic cells are productively infected with herpes simplex virus type 1. J. Virol. 75(13):2001;5958-5964
19. Kruse M., Rosorius O., Kratzer F., et al. Mature dendritic cells infected with herpes simplex virus type 1 exhibit inhibited T-cell stimulatory capacity. J. Virol. 74(15):2000;7127-7136
20. Salio M., Cella M., Suter M., Lanzavecchia A. Inhibition of dendritic cell maturation by herpes simplex virus. Eur. J. Immunol. 29(10):1999;3245-3253
21. Pollara G., Speidel K., Samady L., et al. Herpes simplex virus infection of dendritic cells: balance among activation, inhibition, and immunity. J. Infect. Dis. 187(2):2003;165-178
22. Kadowaki N., Antonenko S., Lau J.Y., Liu Y.J. Natural interferon alpha/beta-producing cells link innate and adaptive immunity. J. Exp. Med. 192(2):2000;219-226
23. Siegal F.P., Kadowaki N., Shodell M., et al. The nature of the principal type 1 interferon-producing cells in human blood. Science. 284(5421):1999;1835- 1837
24. Milone M.C., Fitzgerald-Bocarsly P. The mannose receptor mediates induction of IFN-alpha in peripheral blood dendritic cells by enveloped RNA and DNA viruses. J. Immunol. 161(5):1998;2391-2399
25. Ankel H., Westra D.F., Welling-Wester S., Lebon P. Induction of interferon-alpha by glycoprotein D of herpes simplex virus: a possible role of chemokine receptors. Virology. 251(2):1998;317-326
26. Abendroth A., Morrow G., Cunningham A.L., Slobedman B. Varicella-zoster virus infection of human dendritic cells and transmission to T cells: implications for virus dissemination in the host. J. Virol. 75(13):2001;6183- 6192
27. Morrow G., Slobedman B., Cunningham A.L., Abendroth A. Varicella-zoster virus productively infects mature dendritic cells and alters their immune function. J. Virol. 77(8):2003;4950-4959
28. Li L., Liu D., Hutt-Fletcher L., Morgan A., Masucci M.G., Levitsky V. Epstein-Barr virus inhibits the development of dendritic cells by promoting apoptosis of their monocyte precursors in the presence of granulocyte macrophage-colony-stimulating factor and interleukin-4. Blood. 99(10):2002;3725-3734
29. Halary F., Amara A., Lortat-Jacob H., et al. Human cytomegalovirus binding to DC-SIGN is required for dendritic cell infection and target cell trans-infection. Immunity. 17(5):2002;653-664
30. Beck K., Meyer-Konig U., Weidmann M., Nern C., Hufert F.T. Human cytomegalovirus impairs dendritic cell function: a novel mechanism of human cytomegalovirus immune escape. Eur. J. Immunol. 33(6):2003;1528-1538
31. Raftery M.J., Schwab M., Eibert S.M., Samstag Y., Walczak H., Schonrich G. Targeting the function of mature dendritic cells by human cytomegalovirus: a multilayered viral defense strategy. Immunity. 15(6):2001;997-1009
32. Hahn G., Jores R., Mocarski E.S. Cytomegalovirus remains latent in a common precursor of dendritic and myeloid cells. Proc. Natl. Acad. Sci. U.S.A. 95(7):1998;3937-3942
33. Riegler S., Hebart H., Einsele H., Brossart P., Jahn G., Sinzger C. Monocyte-derived dendritic cells are permissive to the complete replicative cycle of human cytomegalovirus. J. Gen. Virol. 81(Pt 2):2000;393-399
34. Hertel L., Lacaille V.G., Strobl H., Mellins E.D., Mocarski E.S. Susceptibility of immature and mature Langerhans cell-type dendritic cells to infection and immunomodulation by human cytomegalovirus. J. Virol. 77(13):2003;7563-7574
35. Asada H., Klaus-Kovtun V., Golding H., Katz S.I., Blauvelt A. Human herpesvirus 6 infects dendritic cells and suppresses human immunodeficiency virus type 1 replication in coinfected cultures. J. Virol. 73(5):1999;4019-4028
36. Kakimoto M., Hasegawa A., Fujita S., Yasukawa M. Phenotypic and functional alterations of dendritic cells induced by human herpesvirus 6 infection. J. Virol. 76(20):2002;10338-10345
37. Engelmayer J., Larsson M., Subklewe M., et al. Vaccinia virus inhibits the maturation of human dendritic cells: a novel mechanism of immune evasion. J. Immunol. 163(12):1999;6762-6768
38. Seet B.T., Johnston J.B., Brunetti C.R., et al. Poxviruses and immune evasion. Annu. Rev. Immunol. 21:2003;377-423
39. Pichyangkul S., Endy T.P., Kalayanarooj S., et al. A blunted blood plasmacytoid dendritic cell response to an acute systemic viral infection is associated with increased disease severity. J. Immunol. 171(10):2003;5571-5578
40. Libraty D.H., Pichyangkul S., Ajariyakhajorn C., Endy T.P., Ennis F.A. Human dendritic cells are activated by dengue virus infection: enhancement by gamma interferon and implications for disease pathogenesis. J. Virol. 75(8):2001;3501-3508
41. Tassaneetrithep B., Burgess T.H., Granelli-Piperno A., et al. DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells. J. Exp. Med. 197(7):2003;823-829
42. Navarro-Sanchez E., Altmeyer R., Amara A., et al. Dendritic-cell-specific ICAM3-grabbing non-integrin is essential for the productive infection of human dendritic cells by mosquito-cell-derived dengue viruses. EMBO Rep. 4(7):2003;723-728
43. Marovich M., Grouard-Vogel G., Louder M., et al. Human dendritic cells as targets of dengue virus infection. J. Investig. Dermatol. Symp. Proc. 6(3):2001;219-224
44. Wu S.J., Grouard-Vogel G., Sun W., et al. Human skin Langerhans cells are targets of dengue virus infection. Nat. Med. 6(7):2000;816-820
45. Ho L.J., Wang J.J., Shaio M.F., et al. Infection of human dendritic cells by dengue virus causes cell maturation and cytokine production. J. Immunol. 166(3):2001;1499-1506
46. Cella M., Salio M., Sakakibara Y., Langen H., Julkunen I., Lanzavecchia A. Maturation, activation, and protection of dendritic cells induced by double-stranded RNA. J. Exp. Med. 189(5):1999;821-829
47. Cella M., Facchetti F., Lanzavecchia A., Colonna M. Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization. Nat. Immunol. 1(4):2000;305-310
48. Larsson M., Messmer D., Somersan S., et al. Requirment of mature dendritic cells for efficient activation of influenza A-specific memory CD8+ T cells. J. Immunol. 165:2000;1182-1190
49. Plotnicky-Gilquin H., Cyblat D., Aubry J.P., et al. Differential effects of parainfluenza virus type 3 on human monocytes and dendritic cells. Virology. 285(1):2001;82-90
50. Schneider-Schaulies S., ter Meulen V. Triggering of and interference with immune activation: interactions of measles virus with monocytes and dendritic cells. Viral Immunol. 15(3):2002;417-428
51. Bieback K., Lien E., Klagge I.M., et al. Hemagglutinin protein of wild-type measles virus activates toll-like receptor 2 signaling. J. Virol. 76(17):2002;8729-8736
52. Servet-Delprat C., Vidalain P.O., Bausinger H., et al. Measles virus induces abnormal differentiation of CD40 ligand-activated human dendritic cells. J. Immunol. 164(4):2000;1753-1760
53. Murabayashi N., Kurita-Taniguchi M., Ayata M., Matsumoto M., Ogura H., Seya T. Susceptibility of human dendritic cells (DCs) to measles virus (MV) depends on their activation stages in conjunction with the level of CDw150: role of Toll stimulators in DC maturation and MV amplification. Microb. Infect. 4(8):2002;785-794
54. Fugier-Vivier I., Servet-Delprat C., Rivailler P., Rissoan M.C., Liu Y.J., Rabourdin-Combe C. Measles virus suppresses cell-mediated immunity by interfering with the survival and functions of dendritic and T cells. J. Exp. Med. 186(6):1997;813-823
55. Grosjean I., Caux C., Bella C., et al. Measles virus infects human dendritic cells and blocks their allostimulatory properties for CD4+ T cells. J. Exp. Med. 186(6):1997;801-812
56. Bartz H., Buning-Pfaue F., Turkel O., Schauer U. Respiratory syncytial virus induces prostaglandin E2, IL-10 and IL-11 generation in antigen presenting cells. Clin. Exp. Immunol. 129(3):2002;438-445
57. Bartz H., Turkel O., Hoffjan S., Rothoeft T., Gonschorek A., Schauer U. Respiratory syncytial virus decreases the capacity of myeloid dendritic cells to induce interferon-gamma in naive T cells. Immunology. 109(1):2003;49-57
58. Kurt-Jones E.A., Popova L., Kwinn L., et al. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat. Immunol. 1(5):2000;398-401
59. Simmons G., Reeves J.D., Grogan C.C., et al. DC-SIGN and DC-SIGNR bind ebola glycoproteins and enhance infection of macrophages and endothelial cells. Virology. 305(1):2003;115-123
60. Alvarez C.P., Lasala F., Carrillo J., Muniz O., Corbi A.L., Delgado R. C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in trans. J. Virol. 76(13):2002;6841-6844
61. Mahanty S., Hutchinson K., Agarwal S., McRae M., Rollin P.E., Pulendran B. Cutting edge: impairment of dendritic cells and adaptive immunity by Ebola and Lassa viruses. J. Immunol. 170(6):2003;2797-2801
62. Bosio C.M., Aman M.J., Grogan C.C., et al. Ebola and Marburg viruses replicate in monocyte-derived dendritic cells without inducing the production of cytokines and full maturation. J. Infect. Dis. 188(11):2003;1630-1638
63. Lore K., Larsson M. The role of dendritic cells in the pathogenesis of HIV-1 infection. APMIS. 111(7/8):2003;776-788
64. Andrieu M., Chassin D., Desoutter J.F., et al. Downregulation of major histocompatibility class I on human dendritic cells by HIV Nef impairs antigen presentation to HIV-specific CD8+ T lymphocytes. AIDS Res. Hum. Retrovir. 17(14):2001;1365-1370
65. Donaghy H., Gazzard B., Gotch F., Patterson S. Dysfunction and infection of freshly isolated blood myeloid and plasmacytoid dendritic cells in patients infected with HIV-1. Blood. 101(11):2003;4505-4511
66. Larsson M., Fonteneau J., Lirvall M., Haslett P., Lifson J., Bhardwaj N. Activation of HIV-1 specific CD4+ and CD8+ T cells by human dendritic cells: roles of crosspresentation and noninfectious HIV-1 virus. AIDS. 16:2002;1319-1330
67. Takeuchi K., Miyajima N., Nagata N., Takeda M., Tashiro M. Wild-type measles virus induces large syncytium formation in primary human small airway epithelial cells by a SLAM(CD150)-independent mechanism. Virus Res. 94(1):2003;11-16
68. Pope M., Betjes M.G., Romani N., et al. Conjugates of dendritic cells and memory T lymphocytes from skin facilitate productive infection with HIV-1. Cell. 78(3):1994;389-398
69. Larsson M, Fonteneau JF, Lee A, Bhardwaj N. Interations of viruses with dendritic cells. In: Lotze M, Thomson A, editors. Dendritic cells: biology and clinical applications. Academic Press; 2001. p. 505-22 [chapter 36].
70. Somersan S., Larsson M., Fonteneau J.F., Basu S., Srivastava P., Bhardwaj N. Primary tumor tissue lysates are enriched in heat shock proteins and induce the maturation of human dendritic cells. J. Immunol. 167(9):2001;4844-4852
71. Shi Y., Evans J.E., Rock K.L. Molecular identification of a danger signal that alerts the immune system to dying cells [comment]. Nature. 425(6957):2003;516-521
72. Le Bon A., Tough D.F. Links between innate and adaptive immunity via type I interferon. Curr. Opin. Immunol. 14(4):2002;432-436
73. Beg A.A. Endogenous ligands of Toll-like receptors: implications for regulating inflammatory and immune responses. Trends Immunol. 23(11):2002;509-512
74. Barton G.M., Medzhitov R. Toll-like receptor signaling pathways. Science. 300(5625):2003;1524-1525
75. Akira S. Toll-like receptor signaling. J. Biol. Chem. 278(40):2003;38105-38108
76. Kawai T., Takeuchi O., Fujita T., et al. Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes. J. Immunol. 167(10):2001;5887-5894
77. Doyle S., Vaidya S., O'Connell R., et al. IRF3 mediates a TLR3/TLR4-specific antiviral gene program. Immunity. 17(3):2002;251-263
78. Yamamoto M., Sato S., Mori K., et al. Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling. J. Immunol. 169(12):2002;6668-6672
79. Oshiumi H., Matsumoto M., Funami K., Akazawa T., Seya T. TICAM-1 an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction [comment]. Nat. Immunol. 4(2):2003;161-167
80. Kadowaki N., Ho S., Antonenko S., et al. Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J. Exp. Med. 194(6):2001;863-869
81. Krug A., Towarowski A., Britsch S., et al. Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12. Eur. J. Immunol. 31(10):2001;3026-3037
82. Jarrossay D., Napolitani G., Colonna M., Sallusto F., Lanzavecchia A. Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells. Eur. J. Immunol. 31(11):2001;3388-3393
83. Hornung V., Rothenfusser S., Britsch S., et al. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J. Immunol. 168(9):2002;4531-4537
84. Pulendran B., Kumar P., Cutler C.W., Mohamadzadeh M., Van Dyke T., Banchereau J. Lipopolysaccharides from distinct pathogens induce different classes of immune responses in vivo. J. Immunol. 167(9):2001;5067-5076
85. Lore K., Betts M., Brenchley J., et al. Toll-like receptor ligands modulate dendritic cells to augment cytomegalovirus- and HIV-1-specific T cell responses. J. Immunol. 171(8):2003;4320-4328
86. Servant M.J., Grandvaux N., Hiscott J. Multiple signaling pathways leading to the activation of interferon regulatory factor 3. Biochem. Pharmacol. 64(5/6):2002;985-992
87. Levy D.E., Marie I., Prakash A. Ringing the interferon alarm: differential regulation of gene expression at the interface between innate and adaptive immunity. Curr. Opin. Immunol. 15(1):2003;52-58
88. Diebold S.S., Montoya M., Unger H., et al. Viral infection switches non-plasmacytoid dendritic cells into high interferon producers. Nature. 424(6946):2003;324-328
89. Kerkmann M., Rothenfusser S., Hornung V., et al. Activation with CpG-A and CpG-B oligonucleotides reveals two distinct regulatory pathways of type I IFN synthesis in human plasmacytoid dendritic cells. J. Immunol. 170(9):2003;4465-4474
90. Takauji R., Iho S., Takatsuka H., et al. CpG-DNA-induced IFN-alpha production involves p38 MAPK-dependent STAT1 phosphorylation in human plasmacytoid dendritic cell precursors. J. Leukoc. Biol. 72(5):2002;1011-1019
91. Izaguirre A., Barnes B.J., Amrute S., et al. Comparative analysis of IRF and IFN-alpha expression in human plasmacytoid and monocyte-derived dendritic cells. J. Leukoc. Biol. 74(6):2003;1125-1138
92. Muzio M., Bosisio D., Polentarutti N., et al. Differential expression and regulation of toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in dendritic cells. J. Immunol. 164(11):2000;5998-6004
93. Honda K., Sakaguchi S., Nakajima C., et al. Selective contribution of IFN-alpha/beta signaling to the maturation of dendritic cells induced by double-stranded RNA or viral infection. Proc. Natl. Acad. Sci. U.S.A. 100(19):2003;10872-10877
94. Lopez C.B., Garcia-Sastre A., Williams B.R., Moran T.M. Type I interferon induction pathway, but not released interferon, participates in the maturation of dendritic cells induced by negative-strand RNA viruses. J. Infect. Dis. 187(7):2003;1126-1136
95. Suzuki N., Suzuki S., Yeh W.C. IRAK-4 as the central TIR signaling mediator in innate immunity. Trends Immunol. 23(10):2002;503-506
96. Haynes L.M., Moore D.D., Kurt-Jones E.A., Finberg R.W., Anderson L.J., Tripp R.A. Involvement of toll-like receptor 4 in innate immunity to respiratory syncytial virus. J. Virol. 75(22):2001;10730-10737
97. Haeberle H.A., Takizawa R., Casola A., et al. Respiratory syncytial virus-induced activation of nuclear factor-kappaB in the lung involves alveolar macrophages and toll-like receptor 4-dependent pathways. J. Infect. Dis. 186(9):2002;1199-1206
98. Kopp E., Medzhitov R. Recognition of microbial infectio by Toll-like receptors. Curr. Opin. Immunol. 15:2003;396-401
99. Vaidya S.A., Cheng G. Toll-like receptors and innate antiviral responses. Curr. Opin. Immunol. 15:2003;402-407
100. Rassa J.C., Ross S.R. Viruses and Toll-like receptors. Microb. Infect. 5(11):2003;961-968
101. Lund J., Sato A., Akira S., Medzhitov R., Iwasaki A. Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells. J. Exp. Med. 198(3):2003;513-520
102. Krug A., Luker G., Barchet W., Akira S., Colonna M. Herpes Simplex Virus type 1 HSV-1 activates murine natural interferon-producing cells IPC through TollLike Receptor. Blood. 103(4):2004;433-437
103. Karlin S., Doerfler W., Cardon L.R. Why is CpG suppressed in the genomes of virtually all small eukaryotic viruses but not in those of large eukaryotic viruses? J. Virol. 68(5):1994;2889-2897
104. Lee J., Chuang T.H., Redecke V., et al. Molecular basis for the immunostimulatory activity of guanine nucleoside analogs: activation of Toll-like receptor 7. Proc. Natl. Acad. Sci. U.S.A. 100(11):2003;6646-6651
105. Heil F., Ahmad-Nejad P., Hemmi H., et al. The Toll-like receptor 7 (TLR7)-specific stimulus loxoribine uncovers relationship within the TLR7, 8 and 9 subfamily. Eur. J. Immunol. 33(11):2003;2987-2997
106. Matsumoto M., Funami K., Tanabe M., et al. Subcellular localization of toll-like receptor 3 in human dendritic cells. J. Immunol. 171(6):2003;3154-3162
107. Miettinen M., Sareneva T., Julkunen I., Matikainen S. IFNs activate toll-like receptor gene expression in viral infections. Genes Immun. 2(6):2001;349-355
108. Tanabe M., Kurita-Taniguchi M., Takeuchi K., et al. Mechanism of up-regulation of human Toll-like receptor 3 secondary to infection of measles virus-attenuated strains. Biochem. Biophys. Res. Commun. 311(1):2003;39-48
109. Bowie A., Kiss-Toth E., Symons J.A., Smith G.L., Dower S.K., O'Neill L.A. A46R and A52R from vaccinia virus are antagonists of host IL-1 and toll-like receptor signaling [comment]. Proc. Natl. Acad. Sci. U.S.A. 97(18):2000;10162- 10167
110. Harte M.T., Haga I.R., Maloney G., et al. The poxvirus protein A52R targets Toll-like receptor signaling complexes to suppress host defense. J. Exp. Med. 197(3):2003;343-351
111. Geijtenbeek T.B., Kwon D.S., Torensma R., et al. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells [comment]. Cell. 100(5):2000;587-597
112. Soilleux E.J., Morris L.S., Leslie G., et al. Constitutive and induced expression of DC-SIGN on dendritic cell and macrophage subpopulations in situ and in vitro. J. Leukoc. Biol. 71(3):2002;445-457
113. Lozach P.Y., Lortat-Jacob H., de Lacroix de Lavalette A., et al. DC-SIGN and L-SIGN are high affinity binding receptors for hepatitis C virus glycoprotein E2. J. Biol. Chem. 278(22):2003;20358-20366
114. Blomberg S., Eloranta M.L., Magnusson M., Alm G.V., Ronnblom L. Expression of the markers BDCA-2 and BDCA-4 and production of interferon-alpha by plasmacytoid dendritic cells in systemic lupus erythematosus. Arthritis Rheum. 48(9):2003;2524-2532
115. Dzionek A., Inagaki Y., Okawa K., et al. Plasmacytoid dendritic cells: from specific surface markers to specific cellular functions. Hum. Immunol. 63(12):2002;1133-1148
116. Le Bon A., Etchart N., Rossmann C., et al. Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon [comment]. Nat. Immunol. 4(10):2003;1009-1015
117. Goodbourn S., Didcock L., Randall R.E. Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures. J. Gen. Virol. 81(Pt 10):2000;2341-2364
118. Samuel C.E. Antiviral actions of interferons. Clin. Microbiol. Rev. 14(4):2001;778-809
119. Horng T., Barton G.M., Medzhitov R. TIRAP: an adapter molecule in the Toll signaling pathway [comment]. Nat. Immunol. 2(9):2001;835-841
120. Sauder D.N., Smith M.H., Senta-McMillian T., Soria I., Meng T.C. Randomized, single-blind, placebo-controlled study of topical application of the immune response modulator resiquimod in heathly adults. Antimicrob. Agents Chemother. 47(12):2003;3846-3852
121. Bottrel R.L., Yang Y.L., Levy D.E., Tomai M., Reis L.F. The immune response modifier imiquimod requires STAT-1 for induction of interferon, interferon-stimulated genes, and interleukin-6. Antimicrob. Agents Chemother. 43(4):1999;856-861
122. Garcia-Sastre A. Mechanisms of inhibition of the host interferon alpha/beta-mediated antiviral responses by viruses. Microb. Infect. 4(6):2002;647-655
123. Basler C.F., Garcia-Sastre A. Viruses and the type I interferon antiviral system: induction and evasion. Int. Rev. Immunol. 21(4/5):2002;305-337
124. de la Rosa G., Longo N., Rodriguez-Fernandez J.L., et al. Migration of human blood dendritic cells across endothelial cell monolayers: adhesion molecules and chemokines involved in subset-specific transmigration. J. Leukoc. Biol. 73(5):2003;639-649
125. Penna G., Vulcano M., Sozzani S., Adorini L. Differential migration behavior and chemokine production by myeloid and plasmacytoid dendritic cells. Hum. Immunol. 63(12):2002;1164-1171
126. Vanbervliet B., Bendriss-Vermare N., Massacrier C., et al. The inducible CXCR3 ligands control plasmacytoid dendritic cell responsiveness to the constitutive chemokine stromal cell-derived factor 1 (SDF-1)/CXCL12. J. Exp. Med. 198(5):2003;823-830
127. Sallusto F., Lanzavecchia A. Mobilizing dendritic cells for tolerance, priming, and chronic inflammation [comment]. J. Exp. Med. 189(4):1999;611-614
128. Haig D.M. Subversion and piracy: DNA viruses and immune evasion. Res. Vet. Sci. 70(3):2001;205-219
129. Hermans I.F., Silk J.D., Gileadi U., et al. NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells. J. Immunol. 171(10):2003;5140-5147
130. Levy O., Orange J.S., Hibberd P., et al. Disseminated varicella infection due to the vaccine strain of varicella-zoster virus, in a patient with a novel deficiency in natural killer T cells. J. Infect. Dis. 188(7):2003;948-953
131. Skold M., Behar S.M. Role of CD1d-restricted NKT cells in microbial immunity. Infect. Immun. 71(10):2003;5447-5455
132. Biron C.A., Brossay L. NK cells and NKT cells in innate defense against viral infections. Curr. Opin. Immunol. 13(4):2001;458-464
133. Yokoyama W.M., Scalzo A.A. Natural killer cell activation receptors in innate immunity to infection. Microb. Infect. 4(15):2002;1513-1521
134. Diefenbach A., Raulet D.H. Strategies for target cell recognition by natural killer cells. Immunol. Rev. 181:2001;170-184
135. Wilson J.L., Heffler L.C., Charo J., Scheynius A., Bejarano M.T., Ljunggren H.G. Targeting of human dendritic cells by autologous NK cells. J. Immunol. 163(12):1999;6365-6370
136. Matikainen S., Paananen A., Miettinen M., et al. IFN-alpha and IL-18 synergistically enhance IFN-gamma production in human NK cells: differential regulation of Stat4 activation and IFN-gamma gene expression by IFN-alpha and IL-12. Eur. J. Immunol. 31(7):2001;2236-2245
137. Strengell M., Matikainen S., Siren J., et al. IL-21 in synergy with IL-15 or IL-18 enhances IFN-gamma production in human NK and T cells. J. Immunol. 170(11):2003;5464-5469
138. Nguyen K.B., Salazar-Mather T.P., Dalod M.Y., et al. Coordinated and distinct roles for IFN-alpha beta, IL-12, and IL-15 regulation of NK cell responses to viral infection. J. Immunol. 169(8):2002;4279-4287
139. Gerosa F., Baldani-Guerra B., Nisii C., Marchesini V., Carra G., Trinchieri G. Reciprocal activating interaction between natural killer cells and dendritic cells. J. Exp. Med. 195(3):2002;327-333
140. Ferlazzo G., Tsang M.L., Moretta L., Melioli G., Steinman R.M., Munz C. Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J. Exp. Med. 195(3):2002;343-351
141. Terrazzano G., Zanzi D., Palomba C., et al. Differential involvement of CD40, CD80, and major histocompatibility complex class I molecules in cytotoxicity induction and interferon-gamma production by human natural killer effectors. J. Leukoc. Biol. 72(2):2002;305-311
142. Nishioka Y., Nishimura N., Suzuki Y., Sone S. Human monocyte-derived and CD83(+) blood dendritic cells enhance NK cell-mediated cytotoxicity. Eur. J. Immunol. 31(9):2001;2633-2641
143. Mailliard R.B., Son Y.I., Redlinger R., et al. Dendritic cells mediate NK cell help for Th1 and CTL responses: two-signal requirement for the induction of NK cell helper function. J. Immunol. 171(5):2003;2366-2373
144. Mocikat R., Braumuller H., Gumy A., et al. Natural killer cells activated by MHC class I (low) targets prime dendritic cells to induce protective CD8 T cell responses. Immunity. 19(4):2003;561-569
145. Orange J.S., Fassett M.S., Koopman L.A., Boyson J.E., Strominger J.L. Viral evasion of natural killer cells. Nat. Immunol. 3(11):2002;1006-1012
146. Yonezawa A., Morita R., Takaori-Kondo A., et al. Natural alpha interferon-producing cells respond to human immunodeficiency virus type 1 with alpha interferon production and maturation into dendritic cells. J. Virol. 77(6):2003;3777-3784
147. Feldman S.B., Ferraro M., Zheng H.M., Patel N., Gould-Fogerite S., Fitzgerald-Bocarsly P. Viral induction of low frequency interferon-alpha producing cells. Virology. 204(1):1994;1-7
148. Gary-Gouy H., Lebon P., Dalloul A.H. Type I interferon production by plasmacytoid dendritic cells and monocytes is triggered by viruses, but the level of production is controlled by distinct cytokines. J. Interferon Cytokine Res. 22(6):2002;653-659
149. Rissoan M.C., Soumelis V., Kadowaki N., et al. Reciprocal control of T helper cell and dendritic cell differentiation [comment]. Science. 283(5405):1999;1183-1186
150. Payvandi F., Amrute S., Fitzgerald-Bocarsly P. Exogenous and endogenous IL-10 regulate IFN-alpha production by peripheral blood mononuclear cells in response to viral stimulation. J. Immunol. 160(12):1998;5861-5868
151. Soumelis V., Scott I., Liu Y.J., Levy J. Natural type 1 interferon producing cells in HIV infection. Hum. Immunol. 63(12):2002;1206-1212
152. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature. 392:1998;245-252
153. Sallusto F., Mackay C.R., Lanzavecchia A. The role of chemokine receptors in primary, effector, and memory immune responses. Annu. Rev. Immunol. 18:2000;593-620
154. Wu S.J., Grouard-Vogel G., Sun W., et al. Human skin Langerhans cells are targets of dengue virus infection [comment]. Nat. Med. 6(7):2000;816-820
155. Rong Q., Alexander T.S., Koski G.K., Rosenthal K.S. Multiple mechanisms for HSV-1 induction of interferon alpha production by peripheral blood mononuclear cells. Arch. Virol. 148(2):2003;329-344
156. Samady L., Costigliola E., MacCormac L., et al. Deletion of the virion host shutoff protein (vhs) from herpes simplex virus (HSV) relieves the viral block to dendritic cell activation: potential of vhs- HSV vectors for dendritic cell-mediated immunotherapy. J. Virol. 77(6):2003;3768-3776
157. Herr W., Ranieri E., Olson W., Zarour H., Gesualdo L., Storkus W.J. Mature dendritic cells pulsed with freeze-thaw cell lysates define an effective in vitro vaccine designed to elicit EBV-specific CD4(+) and CD8(+) T lymphocyte responses. Blood. 96:2000;1857-1864
158. Subklewe M., Paludan C., Tsang M.L., Steinman R.M., Münz C. Dendritic cells cross-present latency gene products from Epstein-Barr Virus-transformed B cells and expand tumor-reactive CD8(+) killer T cells. J. Exp. Med. 193:2001;405-412
159. Arrode G., Davrinche C. Dendritic cells and HCMV cross-presentation. Curr. Top. Microbiol. Immunol. 276:2003;277-294
160. Arrode G., Boccaccio C., Abastado J.P., Davrinche C. Cross-presentation of human cytomegalovirus pp65 (UL83) to CD8+ T cells is regulated by virus-induced, soluble-mediator-dependent maturation of dendritic cells. J. Virol. 76(1):2002;142-150
161. Moutaftsi M., Mehl A.M., Borysiewicz L.K., Tabi Z. Human cytomegalovirus inhibits maturation and impairs function of monocyte-derived dendritic cells. Blood. 99(8):2002;2913-2921
162. Drillien R., Spehner D., Bohbot A., Hanau D. Vaccinia virus-related events and phenotypic changes after infection of dendritic cells derived from human monocytes. Virology. 268(2):2000;471-481
163. Larsson M., Fonteneau J.F., Somersan S., et al. Efficiency of cross presentation of vaccinia virus-derived antigens by human dendritic cells. Eur. J. Immunol. 31(12):2001;3432-3442. [erratum appears in Eur J Immunol 2002;32(1):307]
164. Ramirez M.C., Sigal L.J. Macrophages and dendritic cells use the cytosolic pathway to rapidly cross-present antigen from live, vaccinia-infected cells. J. Immunol. 169(12):2002;6733-6742
165. Geisbert T.W., Hensley L.E., Larsen T., et al. Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection. Am. J. Pathol. 163(6):2003;2347-2370
166. Klagge I.M., Schneider-Schaulies S. Virus interactions with dendritic cells. J. Gen. Virol. 80(Pt 4):1999;823-833
167. Barron M.A., Blyveis N., Palmer B.E., MaWhinney S., Wilson C.C. Influence of plasma viremia on defects in number and immunophenotype of blood dendritic cell subsets in human immunodeficiency virus 1-infected individuals. J. Infect. Dis. 187(1):2003;26-37
168. Kobelt D., Lechmann M., Steinkasserer A. The interaction between dendritic cells and herpes simplex virus-1. Curr. Top. Microbiol. Immunol. 276:2003;145-161
169. Ploegh H.L. Viral strategies of immune evasion. Science. 280:1998;248-253
170. Petersen J.L., Morris C.R., Solheim J.C. Virus evasion of MHC class I molecule presentation. J. Immunol. 171(9):2003;4473-4478
171. Weber F., Kochs G., Haller O., Staeheli P. Viral evasion of the interferon system: old viruses, new tricks. J. Interferon Cytokine Res. 23(4):2003;209-213
172. Dubois B., Lamy P.J., Chemin K., Lachaux A., Kaiserlian D. Measles virus exploits dendritic cells to suppress CD4+ T-cell proliferation via expression of surface viral glycoproteins independently of T-cell trans-infection. Cell. Immunol. 214(2):2001;173-183
173. Vidalain P.O., Azocar O., Lamouille B., Astier A., Rabourdin-Combe C., Servet-Delprat C. Measles virus induces functional TRAIL production by human dendritic cells. J. Virol. 74(1):2000;556-559
174. Larsson M., Fonteneau J.F., Bhardwaj N. Dendritic cells resurrect antigens from dead cells. Trends Immunol. 22(3):2001;141-148
175. Larsson M., Fonteneau J.F., Bhardwaj N. Cross-presentation of cell-associated antigens by dendritic cells. Curr. Top. Microbiol. Immunol. 276:2003;261-275
176. Bevan M.J. Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay. J. Exp. Med. 143:1976;1283-1288
177. Heath W.R., Carbone F.R. Cross-presentation, dendritic cells, tolerance and immunity. Annu. Rev. Immunol. 19:2001;47-64
178. Heath W.R., Kurts C., Miller J.F.A.P., Carbone F. Cross-tolerance: a pathway for inducing tolerance to peripheral tissue antigens. J. Exp. Med. 187:1998;1549-1553
179. Huang F.-P., Platt N., Wykes M., et al. A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes. J. Exp. Med. 191:2000;435-444
180. Sigal L.J., Rock K.L. Bone marrow-derived antigen-presenting cells are required for the generation of cytotoxic T lymphocyte responses to viruses and use transporter associated with antigen presentation (TAP)-dependent and -independent pathways of antigen presentation. J. Exp. Med. 192:2000;1143-1150
181. Sotomayor E.M., Borrello I., Rattis F.-M., Abrams J., Staveley-O'Carroll K., Levitsky H.I. Cross-presentation of tumor by bone marrow derived antigen presenting cells is the dominant mechanism in the induction of T cell tolerance during B-cell lymphoma progression. Blood. 98(4):2001;1070-1077
182. Bennett S.R.M., Carbone F.R., Karamalis F., Flavell R.A., Miller J.F.A.P., Heath W.R. Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature. 393:1998;478-480
183. den Haan J., Lehar S., Bevan M. CD8+ but not CD8- dendritic cells cross-prime cytotoxic T cells in vivo. J. Exp. Med. 192:2000;1685-1696
184. Pooley J.L., Heath W.R., Shortman K. Intravenous soluble antigen is presented to CD4 T cells by CD8(-) dendritic cells but cross-presented to CD8 T cells by CD8+ dendritic cells. J. Immunol. 166:2001;5327-5330
185. Albert M.L., Sauter B., Bhardwaj N. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature. 392:1998;86-89
186. Rodriguez A., Regnault A., Kleijmeer M., Ricciardi-Castagnoli P., Amigorena S. Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells. Nat. Cell Biol. 1:1999;362-368
187. Li M., Davey G.M., Sutherland R.M., et al. Cell-associated ovalbumin is cross-presented much more efficiently than soluble ovalbumin in vivo. J. Immunol. 166:2001;6099-6103
188. Machy P., Serre K., Leserman L. Class I-restricted presentation of exogenous antigen acquired by Fcgamma receptor-mediated endocytosis is regulated in dendritic cells. Eur. J. Immunol. 30:2000;848-857
189. Tabi Z., Moutaftsi M., Borysiewicz L.K. Human cytomegalovirus pp65- and immediate early 1 antigen-specific HLA class I-restricted cytotoxic T cell responses induced by cross-presentation of viral antigens. J. Immunol. 166:2001;5695-5703
190. Arrode G., Boccaccio C., Lule J., et al. Incoming human cytomegalovirus pp65 (UL83) contained in apoptotic infected fibroblasts is cross-presented to CD8(+) T cells by dendritic cells. J. Virol. 74(21):2000;10018-10024
191. Ferlazzo G., Semino C., Spaggiari G.M., Meta M., Mingari M.C., Melioli G. Dendritic cells efficiently cross-prime HLA class I-restricted cytolytic T lymphocytes when pulsed with both apoptotic and necrotic cells but not with soluble cell-derived lysates. Int. Immunol. 12(12):2000;1741-1747
192. Popescu I., Macedo C., Zeevi A., et al. Ex vivo priming of naive T cells into EBV-specific Th1/Th2 effector cells by mature dendritic cells loaded with apoptotic/necrotic LCL. Am. J. Transplant. 3(11):2003;1369-1377
193. Robinson H.L. New hope for an AIDS vaccine. Nat. Rev. Immunol. 2(4):2002;239-250
194. Lundstrom K. Latest development in viral vectors for gene therapy. Trends Biotechnol. 21(3):2003;117-122
195. Jooss K., Chirmule N. Immunity to adenovirus and adeno-associated viral vectors: implications for gene therapy. Gene Ther. 10(11):2003;955-963
196. Amara R.R., Robinson H.L. A new generation of HIV vaccines. Trends Mol. Med. 8(10):2002;489-495
197. Lundstrom K. Alphavirus vectors for vaccine production and gene therapy. Exp. Rev. Vacc. 2(3):2003;447-459
198. Polo J.M., Gardner J.P., Ji Y., et al. Alphavirus DNA and particle replicons for vaccines and gene therapy. Dev. Biol. 104:2000;181-185